Nicolaj C. Hansson et al. JACC 2016;68:

Slides:

Advertisements

Similar presentations

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.

Advertisements

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

J Am Coll Cardiol. Published online September 28, doi: /j.jacc

From: Functional Status and Quality of Life After Transcatheter Aortic Valve ReplacementA Systematic Review Ann Intern Med. 2014;160(4): doi: /M

Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.

Adel H. Allam et al. JIMG 2011;4:

Alan Rozanski et al. JACC 2005;45:

Glenn N. Levine et al. JACC 2016;68:

Zhi-hui Hou et al. JIMG 2012;5:

Robert W. Yeh et al. JACC 2017;70:

Robert W. Yeh et al. JACC 2017;70:

Median total new lesion volume

Daniel Frenkel et al. JACEP 2016;2:

Patrizio Lancellotti et al. JIMG 2016;9:

Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP,

Dean J. Kereiakes et al. JACC 2017;70:

Alexander Ghanem et al. JACC 2010;55:

Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.

Nat. Rev. Cardiol. doi: /nrcardio

Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:

Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.

Santiago Rivera et al. JACEP 2015;1:

Johannes Steiner et al. JACC 2017;70:

Prakash Harikrishnan et al. JACEP 2015;1:

Ao, aorta; CEOA, corrected effective orifice area; CFD, color-flow Doppler; CW, continuous-wave; DBP, diastolic blood pressure; LV EDP, left ventricular.

Miralem Pasic et al. JCIN 2015;8:1-9

Jonathan Afilalo et al. JACC 2017;j.jacc

John A. Bittl et al. JACC 2016;68:

Khurram Nasir et al. JACC 2015;66:

Prakash Harikrishnan et al. JACEP 2015;1:

Matthew Oster et al. JACC 2019;73:

Kenshi Hayashi et al. JACEP 2016;2:

Transcatheter aortic valve replacement in intermediate-risk patients

Michele Gallo, MD, Gino Gerosa, MD

Björn Redfors et al. JACEP 2017;j.jacep

Michael V. McConnell et al. JACC 2018;71:

Multimodality imaging of aortic stenosis.

Nicole M. Bhave et al. JIMG 2018;11:

Nicole M. Bhave et al. JIMG 2018;11:

Nicole M. Bhave et al. JIMG 2018;11:

Nicole M. Bhave et al. JIMG 2018;11:

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Glenn N. Levine et al. JACC 2011;58:e44-e122

Thomas A. Treibel et al. JACC 2018;71:

Stavros V. Konstantinides et al. JACC 2017;69:

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Thomas Knickelbine et al. JIMG 2009;2:

Rick A. Nishimura et al. JACC 2019;73:

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Matias B. Yudi et al. JACC 2018;71:

Matias B. Yudi et al. JACC 2018;71:

Matias B. Yudi et al. JACC 2018;71:

Commentary: When a choice is not an echo

Fernanda M. Mangione et al. JIMG 2017;10:82-85

Sung-Han Yoon et al. JACC 2017;69:

Ronald K. Binder et al. JCIN 2013;6:

Maxime Berthelot-Richer et al. JIMG 2016;9:

Writing Committee Members et al. JACC 2018;j.jacc

Ander Regueiro et al. JACC 2017;69:

Orly Vardeny et al. JCHF 2016;4:

Ronald K. Binder et al. JCIN 2013;6:

Philippe Pibarot et al. JIMG 2015;8:

Mackram F. Eleid et al. JIMG 2016;9:

Patient selection process in the present study.

Miralem Pasic et al. JCIN 2015;8:1-9

Dee Dee Wang et al. JIMG 2016;9:

Stefan Toggweiler et al. JCIN 2016;9:

NYHA before and after at least 30–60 days after TAVI

Presentation transcript:

Nicolaj C. Hansson et al. JACC 2016;68:2059-2069 THV Thrombosis: Detection by Multidetector Computed Tomography (7%) In this study cohort of 405 patients, larger transcatheter heart valve (THV) size and no post–transcatheter aortic valve replacement (TAVR) warfarin treatment was found to be associated with increased risk of THV thrombosis. Warfarin effectively reverted THV thrombosis and normalized THV function. Nicolaj C. Hansson et al. JACC 2016;68:2059-2069 American College of Cardiology Foundation